Immunotherapeutic Approaches to Sarcoma

Steven A. Rosenberg, Gwendolyn Fyfe, Gwendolyn Fyfe, Richard I. Fisher, Long-term survival update for high-dose recombinant interleukin-2 in patients with renal cell carcinoma. The cancer journal from Scientific American. ,vol. 6, ,(2000)

Seth M Pollack, Achim A Jungbluth, Benjamin L Hoch, Erik A Farrar, Marie Bleakley, David J Schneider, Elizabeth T Loggers, Eve Rodler, Janet F Eary, Ernest U Conrad, III, Robin L Jones, Cassian Yee, NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma. Cancer. ,vol. 118, pp. 4564- 4570 ,(2012) , 10.1002/CNCR.27446

Michael B. Atkins, Michael T. Lotze, Janice P. Dutcher, Richard I. Fisher, Geoffrey Weiss, Kim Margolin, Jeff Abrams, Mario Sznol, David Parkinson, Michael Hawkins, Carolyn Paradise, Lori Kunkel, Steven A. Rosenberg, High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993 Journal of Clinical Oncology. ,vol. 17, pp. 2105- 2116 ,(1999) , 10.1200/JCO.1999.17.7.2105

Satoshi Kawaguchi, Takuro Wada, Kazunori Ida, Yuriko Sato, Satoshi Nagoya, Tomohide Tsukahara, Sigeharu Kimura, Hiroeki Sahara, Hideyuki Ikeda, Kumiko Shimozawa, Hiroko Asanuma, Toshihiko Torigoe, Hiroaki Hiraga, Takeshi Ishii, Shin-ichiro Tatezaki, Noriyuki Sato, Toshihiko Yamashita, Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma. Journal of Translational Medicine. ,vol. 3, pp. 1- 9 ,(2005) , 10.1186/1479-5876-3-1

Anu Sharma, Beata Bode, Gabriela Studer, Holger Moch, Michal Okoniewski, Alexander Knuth, Lotta von Boehmer, Maries van den Broek, Radiotherapy of Human Sarcoma Promotes an Intratumoral Immune Effector Signature Clinical Cancer Research. ,vol. 19, pp. 4843- 4853 ,(2013) , 10.1158/1078-0432.CCR-13-0352

Manfred Lehner, Gabriel Götz, Julia Proff, Niels Schaft, Jan Dörrie, Florian Full, Armin Ensser, Yves A. Muller, Adelheid Cerwenka, Hinrich Abken, Ornella Parolini, Peter F. Ambros, Heinrich Kovar, Wolfgang Holter, Redirecting T Cells to Ewing's Sarcoma Family of Tumors by a Chimeric NKG2D Receptor Expressed by Lentiviral Transduction or mRNA Transfection PLoS ONE. ,vol. 7, pp. e31210- 31210 ,(2012) , 10.1371/JOURNAL.PONE.0031210

Helena R. Chang, Carlos Cordon-Cardo, Alan N. Houghton, Nai-Kong V. Cheung, Murray F. Brennan, Expression of disialogangliosides GD2 and GD3 on human soft tissue sarcomas Cancer. ,vol. 70, pp. 633- 638 ,(1992) , 10.1002/1097-0142(19920801)70:3<633::AID-CNCR2820700315>3.0.CO;2-F

Jung Ryul Kim, Young Jae Moon, Keun Sang Kwon, Jun Sang Bae, Sajeev Wagle, Kyoung Min Kim, Ho Sung Park, Ho Lee, Woo Sung Moon, Myoung Ja Chung, Myoung Jae Kang, Kyu Yun Jang, Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas PLoS ONE. ,vol. 8, pp. e82870- ,(2013) , 10.1371/JOURNAL.PONE.0082870

Steven A Rosenberg, MICHAEL T LOTZE, JAMES C YANG, PAUL M AEBERSOLD, W Marston Linehan, CLAUDIA A SEIPP, DONALD E WHITE, None, Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients. Annals of Surgery. ,vol. 210, pp. 474- 485 ,(1989) , 10.1097/00000658-198910000-00008

Suzanne L Topalian, Charles G Drake, Drew M Pardoll, Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. Current Opinion in Immunology. ,vol. 24, pp. 207- 212 ,(2012) , 10.1016/J.COI.2011.12.009